Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

The 14 million people who received a Johnson & Johnson shot are going to have to wait a few more weeks for answers on boosters due to lack of data, federal health officials said Wednesday.

Why it matters: The CDC currently advises people to stay with the shot they had initially. The effects of mixing doses are still unclear, but "it is anticipated that vaccine boosters will likely be needed," the White House tweeted.

  • Data for the J&J shot is months behind mRNA shots, since the company only received emergency use authorization in March while Pfizer and Moderna received theirs in December.
  • Still, emerging evidence shows people who received adenovirus vaccines like J&J or AstraZeneca would benefit from an additional dose of an mRNA vaccine.
  • Germany and the U.K. have been giving doses of mRNA vaccines to people who got the AstraZeneca vaccine, BBC reports.

What we know: Booster recommendations for J&J recipients were largely left out of the conversation last week when federal health officials announced that immunocompromised Americans can receive an additional dose of the COVID-19 vaccine.

  • J&J anticipates sharing data shortly regarding boosting with the Johnson & Johnson COVID-19 vaccine, a spokesperson tells Axios.
  • A July study from the company claims the shot provides adequate protection against the highly transmissible Delta variant. An independent one said protection decreased, however.

What's happening: The San Francisco health department was the first in the U.S. in early August to make an "accommodation" for J&J recipients to get a supplemental mRNA vaccine dose who have consulted with a doctor.

  • Clinicians have enough information to "provide J&J recipients guidance as to whether they should get a booster," Leana Wen, visiting professor at the George Washington University school of public health, said in a Washington Post op-ed.

What they're saying: It's unfortunate J&J recipients will eventually need a booster considering the single dose was enticing for some, but an mRNA shot is the next best step than getting another dose of the J&J, Phil Felgner, director of University of California, Irvine Vaccine Research and Development Center, tells Axios.

Yes, but: Willingness to get a booster is less prevalent among J&J recipients, a recent poll from Boston Children’s Hospital and the Harvard Medical School shows.

  • About two-thirds of those who received the Moderna or Pfizer vaccines want a booster, compared with 44% who received J&J.
  • 13% of J&J explicitly said they do not want a booster shot, more than two times as many Moderna and Pfizer recipients.

Go deeper

Updated Oct 19, 2021 - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Vaccines: Mix-and-matching gains momentum — Boosters overtake first doses in U.S. — Pfizer to vaccinate Brazilian cityPanel endorses J&J booster.
  2. Health: Age is still a huge coronavirus risk factor — Unvaccinated 11x more likely to die from COVID — 5x more police officers died from COVID than guns.
  3. Politics: Over 30 states limited public health powers — Pope Francis calls on companies to release vaccine patents — Melbourne, "world's most locked-down city," to lift stay-at-home orders.
  4. Education: Education secretary reveals limits to Biden’s mask push on states — LA extends deadline for school employee vaccinations — Parent sues Wisconsin school district after child tests positive.
  5. Variant tracker: Where different strains are spreading.
Oct 19, 2021 - Health

Supreme Court declines to block Maine health care workers vaccine mandate

A Maine health care worker prepares vaccine dose. Photo: Gregory Rec/Portland Press Herald via Getty Images

The U.S. Supreme Court on Tuesday declined to hear an emergency appeal of a vaccine mandate for Maine health care workers.

The big picture: The mandate, which was announced in August by Democratic Gov. Janet Mills, says that Maine health care workers need to be vaccinated by Oct. 29 or risk losing their jobs and not qualifying for unemployment benefits.

GE to mandate COVID vaccinations for U.S. workers

Photo: Sebastien Bozon/AFP via Getty Images

General Electric will require all of its workers in the U.S. to be vaccinated against COVID-19, citing President Biden's executive order for federal contractors, the company confirmed to Axios on Tuesday.

Why it matters: General Electric is the latest in a slew of major companies to mandate the vaccine for workers, following in the footsteps of American Airlines, Tyson Foods and Microsoft, among others.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!